Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Up 2.1% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific (NYSE: TMO) is a leading company in the scientific research and laboratory equipment industry. With a market capitalization of $198.58 billion, TMO has shown consistent growth and outperformance in the market over the past two decades.

Why is Thermo Fisher Scientific Inc going up?

TMO stock is up 2.1% on Jan 6, 2025 15:36

• Strong bullish movement today can be attributed to TMO's impressive track record of outperforming the market over the last 20 years, with an annualized basis return of 15.55%.
• Investors are likely showing increased confidence in TMO's continued success and growth prospects, leading to a surge in buying activity.
• The positive sentiment surrounding TMO may have been further fueled by favorable market conditions and overall optimism in the scientific research sector.
• This bullish momentum is a testament to TMO's strong market position and investor appeal, reflecting a promising outlook for the company's future performance.

TMO Price Chart

TMO Technical Analysis

TMO News

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Thermo Fisher Scientific ( NYSE:TMO )

Thermo Fisher Scientific TMO has outperformed the market over the past 20 years by 7.25% on an annualized basis producing an average annual return of 15.55%. Currently, Thermo Fisher Scientific has a market capitalization of $198.58 billion.

https://www.benzinga.com/insights/news/25/01/42757376/heres-how-much-you-would-have-made-owning-thermo-fisher-scientific-stock-in-the-last-20-years

Trending Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 8.5% Today

Stellar ($XLM) Crypto Forecast: Up 12.9% Today

Chainlink ($LINK) Crypto Forecast: Up 5.8% Today

XRP ($XRP) Crypto Forecast: Up 12.0% Today

NEO ($NEO) Crypto Forecast: Up 5.0% Today

Peanut Squirrel ($PNUT) Crypto Forecast: Down 5.5% Today

Polkadot ($DOT) Crypto Forecast: Up 5.0% Today

Cardano ($ADA) Crypto Forecast: Up 9.1% Today

Avalanche ($AVAX) Crypto Forecast: Up 5.3% Today

Decentraland ($MANA) Crypto Forecast: Up 5.2% Today

Thermo Fisher Scientific Inc Price History

06.00.2025 - TMO Stock was up 2.1%

• Strong bullish movement today can be attributed to TMO's impressive track record of outperforming the market over the last 20 years, with an annualized basis return of 15.55%.
• Investors are likely showing increased confidence in TMO's continued success and growth prospects, leading to a surge in buying activity.
• The positive sentiment surrounding TMO may have been further fueled by favorable market conditions and overall optimism in the scientific research sector.
• This bullish momentum is a testament to TMO's strong market position and investor appeal, reflecting a promising outlook for the company's future performance.

25.09.2023 - TMO Stock was down 6.0%

• Thermo Fisher Scientific Inc. (TMO) experienced a strong bearish movement today.
• The company reported lower revenues in its third quarter, with a 1% decrease compared to the previous year.
• Thermo Fisher also lowered its full-year financial outlook, citing weak biotech demand and a challenging macro environment.
• This news of lower revenues and a lowered outlook likely contributed to the bearish movement in TMO's stock price.

02.09.2023 - TMO Stock was down 1.7%

• Thermo Fisher Scientific (TMO) experienced a strong bearish movement today.
• The stock rating for TMO was lowered by StockNews.com.
• Despite the overall market dip, TMO managed to gain slightly.
• The bearish movement could be attributed to Bernstein's bearish outlook on Illumina, a competitor in the medtech industry.

31.09.2023 - TMO Stock was up 5.4%

• Unusual options activity suggests a bullish stance on TMO, indicating positive sentiment among investors.
• The acquisition of new positions by Peterson Financial Group Inc. and Apollon Wealth Management LLC also indicates confidence in TMO's growth potential.
• The reduction in stock holdings by Cognios Beta Neutral Large Cap Fund LP may be a minor factor, but overall sentiment remains bullish.
• The upgrade in rating to "Buy" by StockNews.com further supports the positive outlook for TMO.
• Overall, the bullish movement in TMO's stock today can be attributed to the positive sentiment among investors, as indicated by unusual options activity and the acquisition of new positions by prominent financial firms.

01.01.2024 - TMO Stock was down 5.1%

• The bearish movement in TMO's stock today could be attributed to the warning about lower-than-expected demand for 2024. This news may have raised concerns among investors about the company's future growth prospects. Additionally, the overall market sentiment towards biotech companies and their product spending could have contributed to the downward movement.

23.03.2024 - TMO Stock was up 5.0%

• Thermo Fisher Scientific is experiencing a surge in options activity, with deep-pocketed investors adopting a bullish approach towards the company, indicating confidence in its future prospects.
• The positive outlook for the Cell Cryopreservation Market, in which Thermo Fisher Scientific is a key player, could be contributing to the bullish movement as investors anticipate increased demand for the company's products and services.
• The overall market is eagerly awaiting key events such as the US core PCE print and corporate earnings reports, with Thermo Fisher Scientific standing out as a potential attractive valuation option, further attracting investors to the stock.
• The combination of favorable market conditions, positive industry trends, and investor sentiment towards Thermo Fisher Scientific could be driving the stock's strong bullish movement today.

10.06.2023 - TMO Stock was up 0.8%

• The bullish movement in TMO stock today could be attributed to the following factors:
• 1. Acquisition of CorEvitas: Thermo Fisher Scientific agreed to acquire biopharmaceutical data provider CorEvitas from Audax Group for $913 million in cash. This strategic acquisition could enhance Thermo Fisher's data intelligence capabilities and expand its presence in the biopharmaceutical industry.
• 2. Positive market sentiment: Despite concerns raised by Cleveland Research about demand in the toolmakers industry, Thermo Fisher Scientific's strong position in the life sciences sector and its continued growth potential may have instilled confidence among investors, leading to the bullish movement.
• 3. Strong performance: Thermo Fisher Scientific is known for its consistent performance and strong financials. The company's ability to navigate through tough comparables and its resilience during the pandemic may have contributed to the positive market sentiment and the bullish movement in its stock.

25.06.2023 - TMO Stock was up 1.5%

• Thermo Fisher Scientific (TMO) had a strong bullish movement today, and here's why:
• Thermo Fisher Scientific has consistently outperformed the market over the past 15 years, with an average annual return of 16.42%. This long-term track record of success likely contributed to the bullish movement.
• Despite a slight dip of -0.3% in the previous trading session, the overall market gains and positive outlook for Thermo Fisher in the second quarter earnings report could have boosted investor confidence and led to the bullish movement.
• The favorable business mix and new launches by Thermo Fisher in the second quarter are expected to have driven growth, further supporting the bullish movement.
• In summary, Thermo Fisher Scientific's strong bullish movement today can be attributed to its consistent outperformance, positive market sentiment, and anticipated growth in the second quarter.

19.06.2023 - TMO Stock was up 2.4%

• Thermo Fisher Scientific (TMO) had a bullish market movement today.
• The positive market movement could be attributed to the company's strong performance in the second quarter, driven by a favorable business mix and new product launches.
• Additionally, the long-term outperformance of TMO in the market, as highlighted in an article from Benzinga, may have contributed to investor confidence and further buying interest in the stock.
• The launch of Thermo Fisher's Diomni Enterprise Software, as mentioned in an article from Zacks Commentary, could have also generated positive sentiment and potential growth prospects for the company.

01.06.2024 - TMO Stock was down 1.4%

• The bearish movement in TMO's stock today may be due to changes in investor focus within the biotech sector.
• The decline in vaccine sales post-pandemic and the current emphasis on long-term health solutions could be prompting investors to adjust their portfolios away from companies like TMO.
• Significant fund investors taking a bullish stance on TMO, as evidenced by options market data, could imply a short-term market correction rather than a sustained trend, which may be influencing today's bearish movement.
• It is crucial for traders to monitor evolving market dynamics, changing trends, and investor sentiments to make informed decisions within the biotech sector.

25.06.2024 - TMO Stock was up 5.7%

• Thermo Fisher Scientific (TMO) had a strong bullish movement today due to several positive factors:
• The company showcased its latest diagnostics innovations at the Association for Diagnostics & Laboratory Medicine Conference, highlighting industry developments and potential growth opportunities.
• Thermo Fisher's CEO, Marc Casper, had a positive discussion with Jim Cramer on "Mad Money," which likely boosted investor confidence.
• The company's Q2 earnings beat estimates and raised its full-year guidance, indicating strong financial performance and future prospects.
• Overall, these factors contributed to investor optimism and drove the bullish movement in TMO's stock price.

25.06.2024 - TMO Stock was up 5.3%

• Thermo Fisher Scientific presented its latest innovations at a conference, showcasing a dedication to advancements in diagnostics that probably bolstered investor confidence.
• A recent interview with the CEO on a finance show could have offered insights into the company's strong quarterly performance, potentially attracting more investor attention.
• TMO exceeded earnings expectations in Q2 and raised its fiscal year guidance, indicating strong financial performance and growth prospects, likely contributing to the stock's upward movement.
• Despite a slight revenue decline in Q2, the completion of the Olink acquisition and the improved profit forecast highlighted TMO's strategic efforts to strengthen its market position and profitability, reinforcing positive market sentiment towards the stock.